NCT06850441

Brief Summary

This clinical trial aimed to examine the effects of anti-stigma psychoeducation based on the Roy Adaptation Model on stigma and quality of life in individuals with Type 1 Diabetes.The main questions it aims to answer are:

  1. 1.Does anti-stigma psychoeducation reduce stigma of individuals diagnosed with Type 1 Diabetes?
  2. 2.Does anti-stigma psychoeducation improve the quality of life of individuals diagnosed with Type 1 Diabetes?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 22, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

April 28, 2026

Status Verified

February 1, 2025

Enrollment Period

8 months

First QC Date

February 22, 2025

Last Update Submit

April 26, 2026

Conditions

Keywords

Diabetes Mellitus, Type IStigmaQuality of lifeRoy Adaptation Model

Outcome Measures

Primary Outcomes (1)

  • Type 1 Diabetes Stigma Assessment Scale

    Type 1 Diabetes Stigma Assessment Scale was developed by Browne et al. in 2017 to assess perceived and experienced stigma in adults diagnosed with type 1 diabetes. The scale consists of 19 items. The scale has 3 sub-dimensions; "treated differently", "Blame and judgment" and "Identity concerns" Each item is scored on a 5-point Likert scale. (1=strongly disagree, 2=disagree, 3=not sure, 4=agree, 5=strongly agree). Item scores are added to obtain the sub-dimensions and total score of the scale. A high score indicates an increase in perceived and felt stigma.

    0 day, 7 weeks, 3 months

Secondary Outcomes (1)

  • Short Form-36

    0 day, 7 weeks, 3 months

Study Arms (2)

Psychoeducation Group

EXPERIMENTAL

The education is a group psychoeducation. Education methods such as role-play, discussion, demonstration, and narration will be applied. The education will be held once a week and will be completed in 7 weeks. Psychoeducation topics include adaptation to stigma in type 1 diabetes, coping, diabetes management, social life, self-esteem, roles in life and impact on life. Concepts such as stigma, blame, judgment, discrimination, shame and stereotyped thoughts will be included.

Other: Psychoeducation

Control Group

NO INTERVENTION

No intervention

Interventions

The education is a group psychoeducation. Education methods such as role-play, discussion, demonstration, and narration will be applied. The education will be held once a week and will be completed in 7 weeks. Psychoeducation topics include adaptation to stigma in type 1 diabetes, coping, diabetes management, social life, self-esteem, roles in life and impact on life. Concepts such as stigma, blame, judgment, discrimination, shame and stereotyped thoughts will be included.

Psychoeducation Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Type 1 diabetes at least 6 months ago,
  • Being between the ages of 18 and 75,
  • Speaking and understanding Turkish,

You may not qualify if:

  • Having hearing and vision impairment
  • Being diagnosed with mental retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University

Izmir, Bornova, 35040, Turkey (Türkiye)

Location

Related Publications (3)

  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

  • Browne JL, Ventura AD, Mosely K, Speight J. Measuring Type 1 diabetes stigma: development and validation of the Type 1 Diabetes Stigma Assessment Scale (DSAS-1). Diabet Med. 2017 Dec;34(12):1773-1782. doi: 10.1111/dme.13507.

  • Satil EM, Arabaci LB. Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale. North Clin Istanb. 2022 Dec 12;9(6):654-662. doi: 10.14744/nci.2021.36937. eCollection 2022.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Social Stigma

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesSocial BehaviorBehavior

Study Officials

  • Seyda Dülgerler, PhD

    Ege University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
A diabetes education nurse will identify participants and assign numbers to the identified participants. A statistician will randomize the participant numbers. A different nurse will place the participants in the experimental and control groups according to the numbers. A statistician will evaluate the results of the education. Thus, the researcher will be blinded in both the participant selection and the outcome evaluation stages.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Intervention group to be given group psychoeducation The control group to continue their routine treatments and not receive intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 22, 2025

First Posted

February 27, 2025

Study Start

July 1, 2024

Primary Completion

February 17, 2025

Study Completion

February 28, 2025

Last Updated

April 28, 2026

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

This experimental study is a thesis study. In order to preserve originality, I do not approve of sharing it.

Locations